Pfizer
Crizotinib-xalkori
"Crizotinib" is the Drug / Molecule content in "Xalkori”. It has an aminopyridine structure, and functions as a protein kinase inhibitor Crizotinib blocks an enzyme called anaplastic lymphoma kinase (ALK). Blocking this enzyme stops the growth of cells.
Indication
Crizotinib is used for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in a gene called ALK (anaplastic lymphoma kinase).
Note
Precaution
- Crizotinib is a prescription drug and should be used under proper medical guidance and advice.
- Do not receive any kind of immunization or vaccination without your doctor's approval while taking Crizotinib.
Strength
200 mg & 250 mg
Packing
1 X 60 Tablets (Bottle)
Storage
Store at room Temperature (25 C).
Was this page helpful?
Related Products
CIPLA LTD. (INDIA)
Pirfenex
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Gefitinib-geftinat
Astra Zeneca
Iressa-geftinat
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)